{"id":536091,"date":"2021-09-09T07:03:13","date_gmt":"2021-09-09T11:03:13","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\/"},"modified":"2021-09-09T07:03:13","modified_gmt":"2021-09-09T11:03:13","slug":"4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\/","title":{"rendered":"4D pharma to Participate in Upcoming Virtual Investor Conferences in September"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>4D pharma to Participate in Upcoming Virtual Investor Conferences in September<\/b><\/p>\n<p>LEEDS, England&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<b>4D pharma plc (AIM: DDDD, NASDAQ: LBPS)<\/b>, a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces that 4D pharma management will present at the following virtual investor conferences:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li><b>H.C. Wainwright 23rd Annual Global Investment Conference<\/b> at 07:00 ET (12:00 BST) on Monday, September 13, 2021\n<\/li>\n<li><b>Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit <\/b>at 08:15 ET (13:15 BST) on Wednesday, September 22, 2021\n<\/li>\n<\/ul>\n<p>\nA webcast of each presentation will be available via the \u2018Events\u2019 section of the 4D pharma website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.4dpharmaplc.com%2F&amp;esheet=52488210&amp;newsitemid=20210909005080&amp;lan=en-US&amp;anchor=www.4dpharmaplc.com&amp;index=1&amp;md5=f4b1a57bbf5d6cbc0722adeee7bf0ab1\">www.4dpharmaplc.com<\/a>. Archived replays of the webcasts will be available for 90 days following the presentation.\n<\/p>\n<p><strong>About 4D pharma<\/strong><\/p>\n<p>\n4D pharma is a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacterium, that is applicable to the prevention, treatment or cure of a disease. 4D has developed a proprietary platform, MicroRx\u00ae, that rationally identifies Live Biotherapeutics based on a deep understanding of function and mechanism.\n<\/p>\n<p>\n4D pharma&#8217;s Live Biotherapeutic products (LBPs) are orally delivered single strains of bacteria that are naturally found in the healthy human gut. The Company has five clinical programs, namely a Phase I\/II study of MRx0518 in combination with KEYTRUDA (pembrolizumab) in solid tumors, a Phase I study of MRx0518 in a neoadjuvant setting for patients with solid tumors, a Phase I study of MRx0518 in patients with pancreatic cancer, a Phase I\/II study of MRx-4DP0004 in asthma, and Blautix\u00ae in Irritable Bowel Syndrome (IBS) which has completed a successful Phase II trial. Preclinical-stage programs include candidates for CNS disease such as Parkinson&#8217;s disease and other neurodegenerative conditions. The Company has a research collaboration with MSD, a tradename of Merck &amp; Co., Inc., Kenilworth, NJ, USA, to discover and develop Live Biotherapeutics for vaccines.\n<\/p>\n<p>\nFor more information, refer to <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.4dpharmaplc.com%2F&amp;esheet=52488210&amp;newsitemid=20210909005080&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.4dpharmaplc.com&amp;index=2&amp;md5=70a32afff932557a3e324d103ffb843e\">https:\/\/www.4dpharmaplc.com<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210909005080r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210909005080\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210909005080\/en\/<\/a><\/span><\/p>\n<p><strong>4D pharma<br \/>\n<\/strong><br \/>Investor Relations: <a rel=\"nofollow\" href=\"mailto:ir@4dpharmaplc.com\">ir@4dpharmaplc.com<\/a><\/p>\n<p><strong>N+1 Singer &#8211; Nominated Adviser and Joint Broker<\/strong> +44 (0)20 7496 3000<br \/>\n<br \/>Philip Davies \/ Iqra Amin \/ James Fischer (Corporate Finance)<br \/>\n<br \/>Tom Salvesen (Corporate Broking)\n<\/p>\n<p><strong>Bryan Garnier &amp; Co. Limited &#8211; Joint Broker<\/strong> +44 (0)20 7332 2500<br \/>\n<br \/>Dominic Wilson \/ Phil Walker\n<\/p>\n<p><strong>Stern Investor Relations, Inc.<\/strong> +1-212-362-1200<br \/>\n<br \/>Julie Seidel <a rel=\"nofollow\" href=\"mailto:Julie.seidel@sternir.com\">Julie.seidel@sternir.com<\/a><\/p>\n<p><strong>Image Box Communications<\/strong> +44 (0)20 8943 4685<br \/>\n<br \/>Neil Hunter \/ Michelle Boxall<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:neil@ibcomms.agency\">neil@ibcomms.agency<\/a> \/ <a rel=\"nofollow\" href=\"mailto:michelle@ibcomms.agency\">michelle@ibcomms.agency<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United Kingdom Europe<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Oncology Health Infectious Diseases Clinical Trials Pharmaceutical Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>4D pharma to Participate in Upcoming Virtual Investor Conferences in September LEEDS, England&#8211;(BUSINESS WIRE)&#8211;4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces that 4D pharma management will present at the following virtual investor conferences: H.C. Wainwright 23rd Annual Global Investment Conference at 07:00 ET (12:00 BST) on Monday, September 13, 2021 Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit at 08:15 ET (13:15 BST) on Wednesday, September 22, 2021 A webcast of each presentation will be available via the \u2018Events\u2019 section of the 4D pharma website at www.4dpharmaplc.com. Archived replays of the webcasts will be available for 90 days following &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;4D pharma to Participate in Upcoming Virtual Investor Conferences in September&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-536091","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>4D pharma to Participate in Upcoming Virtual Investor Conferences in September - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"4D pharma to Participate in Upcoming Virtual Investor Conferences in September - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"4D pharma to Participate in Upcoming Virtual Investor Conferences in September LEEDS, England&#8211;(BUSINESS WIRE)&#8211;4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces that 4D pharma management will present at the following virtual investor conferences: H.C. Wainwright 23rd Annual Global Investment Conference at 07:00 ET (12:00 BST) on Monday, September 13, 2021 Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit at 08:15 ET (13:15 BST) on Wednesday, September 22, 2021 A webcast of each presentation will be available via the \u2018Events\u2019 section of the 4D pharma website at www.4dpharmaplc.com. Archived replays of the webcasts will be available for 90 days following &hellip; Continue reading &quot;4D pharma to Participate in Upcoming Virtual Investor Conferences in September&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-09T11:03:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210909005080r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"4D pharma to Participate in Upcoming Virtual Investor Conferences in September\",\"datePublished\":\"2021-09-09T11:03:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\\\/\"},\"wordCount\":439,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210909005080r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\\\/\",\"name\":\"4D pharma to Participate in Upcoming Virtual Investor Conferences in September - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210909005080r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-09-09T11:03:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210909005080r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210909005080r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"4D pharma to Participate in Upcoming Virtual Investor Conferences in September\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"4D pharma to Participate in Upcoming Virtual Investor Conferences in September - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\/","og_locale":"en_US","og_type":"article","og_title":"4D pharma to Participate in Upcoming Virtual Investor Conferences in September - Market Newsdesk","og_description":"4D pharma to Participate in Upcoming Virtual Investor Conferences in September LEEDS, England&#8211;(BUSINESS WIRE)&#8211;4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces that 4D pharma management will present at the following virtual investor conferences: H.C. Wainwright 23rd Annual Global Investment Conference at 07:00 ET (12:00 BST) on Monday, September 13, 2021 Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit at 08:15 ET (13:15 BST) on Wednesday, September 22, 2021 A webcast of each presentation will be available via the \u2018Events\u2019 section of the 4D pharma website at www.4dpharmaplc.com. Archived replays of the webcasts will be available for 90 days following &hellip; Continue reading \"4D pharma to Participate in Upcoming Virtual Investor Conferences in September\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-09T11:03:13+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210909005080r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"4D pharma to Participate in Upcoming Virtual Investor Conferences in September","datePublished":"2021-09-09T11:03:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\/"},"wordCount":439,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210909005080r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\/","name":"4D pharma to Participate in Upcoming Virtual Investor Conferences in September - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210909005080r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-09-09T11:03:13+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210909005080r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210909005080r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4d-pharma-to-participate-in-upcoming-virtual-investor-conferences-in-september\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"4D pharma to Participate in Upcoming Virtual Investor Conferences in September"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/536091","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=536091"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/536091\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=536091"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=536091"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=536091"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}